This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Anna Maria Emde: Innovator in Cellular Stress-Related Disease Treatment
Introduction
Anna Maria Emde is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of motor neuron diseases and other cellular stress-related conditions. Her innovative approach has the potential to improve the lives of many individuals suffering from these debilitating diseases.
Latest Patents
Anna Maria Emde holds 1 patent for her groundbreaking work titled "Methods of diagnosing and treating motor neuron diseases and other cellular stress-related diseases." This patent outlines a method for treating cellular stress-related diseases by administering a therapeutically effective amount of an agent that enhances the processing of pre-miRNA. This innovative method aims to provide effective treatment options for individuals in need.
Career Highlights
Throughout her career, Anna Maria Emde has been associated with Yeda Research and Development Co. Ltd., where she has focused on advancing research in her field. Her dedication to innovation and her commitment to improving patient outcomes have established her as a respected figure in the medical research community.
Collaborations
Anna Maria Emde has collaborated with notable professionals in her field, including her coworker Eran Hornstein. These collaborations have further enriched her research and contributed to the development of effective treatment methodologies.
Conclusion
Anna Maria Emde's contributions to the field of cellular stress-related diseases exemplify the impact of innovative research on healthcare. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile